Collegium Pharmaceutical (COLL)
(Delayed Data from NSDQ)
$30.07 USD
+0.21 (0.70%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $30.06 -0.01 (-0.03%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth B Momentum A VGM
Fundamental Charts
About Dividend Yield (TTM)
Collegium Pharmaceutical, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Drugs industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
COLL 30.07 +0.21(0.70%)
Will COLL be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for COLL based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for COLL
Collegium Pharmaceutical (COLL) Q2 Earnings Preview: What's in the Cards?
Wall Street Analysts See a 33.91% Upside in Collegium Pharmaceutical (COLL): Can the Stock Really Move This High?
COLL: What are Zacks experts saying now?
Zacks Private Portfolio Services
Are Investors Undervaluing Collegium Pharmaceutical (COLL) Right Now?
Compared to Estimates, Collegium Pharmaceutical (COLL) Q1 Earnings: A Look at Key Metrics
Collegium Pharmaceutical (COLL) Q1 Earnings and Revenues Surpass Estimates
Other News for COLL
Collegium Pharmaceutical Breaks Below 200-Day Moving Average - Notable for COLL
Collegium Pharmaceutical Inc (COLL) Announces Q2 2025 Financial Results Release Date | COLL ...
Collegium Pharmaceutical Breaks Above 200-Day Moving Average - Bullish for COLL
Collegium announces $150M share repurchase program
Collegium Pharmaceutical board authorizes $150M share repurchase program